SynthesisPloS one2013

A systematic review and methodological evaluation of published cost-effectiveness analyses of aromatase inhibitors versus tamoxifen in early stage breast cancer.

Ava A John-Baptiste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.